CAMBRIDGE ENTERPRISE LIMITED;CAMBRIDGE UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
发明人:
CLARK, ANDREW,EWAN, PAMELA
申请号：
CA2867529
公开号：
CA2867529A1
申请日:
2012.03.16
申请国别(地区):
CA
年份:
2012
代理人:
摘要：
The present invention relates to oral immunotherapy for the desensitisation of patients who are hypersensitive to peanut allergen. The immunotherapy comprises increasing the oral dose daily dose of peanut protein administered to the patient at intervals of at least 2 weeks in a series of increments from an initial dose to a maximum dose, the series of dose increments including 2mg, 5mg, 12.5mg, 25mg, 50mg, 0mg, 200mg, 400mg and 800mg； administering a daily oral dose of the maximum dose of peanut protein for at least 2 years and then administering a weekly oral dose of the maximum dose of peanut protein for at least 2 years.
